AMGN vs ASTH · P/E 24, rev $10.05B vs P/E 34, rev $1.94B
Amgen Inc (AMGN) versus Astrana Health Inc (ASTH) — a side-by-side from cached financials, not a winner call.
Amgen Inc (AMGN) is a drug manufacturers - general company listed on US.
Astrana Health Inc (ASTH) is a medical care facilities company listed on US.
Latest reported AMGN revenue for 2026-06-30 was $10.05B. Net income was $2.38B. Revenue was up 16.7% from 2026-03-31 to 2026-06-30. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.
Latest reported ASTH revenue for 2026-06-30 was $1.94B. Net income was $34.2M. ASTH currently screens at market cap $1.13B and trailing P/E 33.5.
AMGN currently screens at market cap $188.67B and trailing P/E 24.3. ASTH currently screens at market cap $1.13B and trailing P/E 33.5.
Not investment advice. Open the AMGN and ASTH stock pages for the full models.
Not investment advice.